Vaccine

COVID-19: Pfizer-BioNTech vaccine deliveries could start by this month, if ‘all goes well’

In a good news, BioNTech Chief Executive Ugur Sahin on Wednesday (November 18) said that deliveries of coronavirus vaccine developed by BioNTech-Pfizer could come as early as Christmas this year, if 'all goes well'. "If all goes well I could imagine that we gain approval (from US FDA) in the second half of December and start deliveries before Christmas, but really only if all goes positively,” he told Reuters TV. Sahin added that the US Food and Drug Administration could grant emergency-use of the vaccine in December…
Read More

Serum Institute of India gets DCGI permission to restart phase 2, 3 trials of coronavirus COVID-19 vaccine

The Serum Institute of India (SII) is all set to restart its phase two and three clinical trials for the COVID-19 vaccine after getting the nod from the Drugs Controller General of India (DCGI). According to ANI, the SII had sought permission from the DGCI to restart the re-enrollment procedure for COVID-19 vaccine which is being developed by AstraZeneca and Oxford University following the Data Safety Monitoring Board (DSMB) recommendations. "You (SII) may recommence the clinical trial dated August 2, 2020, as recommended by the DSMB, India…
Read More

Serum Institute pauses COVID-19 vaccine trials in India

Serum Institute of India (SII) on Thursday said it is pausing clinical trials of AstraZeneca Oxford COVID-19 vaccine candidate in the country. Earlier this week, AstraZeneca said it had paused the trials because of 'an unexplained illness' in a participant in the study. However, SII on Wednesday said it was continuing with the trials and had not faced any issues. SII's latest announcement also comes against the backdrop of the central drug regulator DCGI issuing a show-cause notice to SII for not informing it about AstraZeneca pausing…
Read More

3 coronavirus vaccines at different stage of trials in India, country ready for its mass production: PM Narendra Modi in Independence Day speech

India is ready to mass-produce coronavirus COVID-19 vaccines to distribute across the country when scientists give the go-ahead to do so, Prime Minister Narendra Modi said in his Independence Day speech on Saturday (August 15). "Not one, not two, as many as three coronavirus vaccines are being tested in India," the Prime Minister said from the ramparts of the Red Fort in the old quarters of Delhi. "The country is also ready for mass production of those vaccines." He said that 130 crore Indians took the pledge…
Read More

Oxford COVID-19 vaccine trials to begin in India: Coronavirus vaccines in final phase of testing

The outbreak of the novel coronavirus (SARS-CoV-2) has triggered an international effort to develop a safe and effective vaccine against COVID-19, perhaps at breakneck speed. Several experimental vaccines have shown promising results in early trials, rising hopes that one will exist before the end of the year. According to the World Health Organization (WHO), at least 26 vaccines are in clinical evaluation with six of them in late-stage, phase 3 trials. As of July 31, WHO’s draft landscape of COVID-19 vaccines shows that some 139 candidate vaccines…
Read More
No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.
Exit mobile version